Ascension Healthcare Development Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 4

Ascension Healthcare Development General Information

Description

Developer of novel antibacterial agents designed to treat bacterial infections. The company engages in exploring new product opportunities both within its existing candidate series and from new agents with the potential to offer significant advantages over current therapies, enabling people suffering from bacterial infections to get the advantage over current therapies.

Contact Information

Formerly Known As
Cantab Anti-infectives Limited, Cantab Anti Infectives
Ownership Status
Out of Business
Financing Status
Corporation
Corporate Office
  • BioPark Hertfordshire
  • Broadwater Road
  • Welwyn Garden City AL7 3AX
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • BioPark Hertfordshire
  • Broadwater Road
  • Welwyn Garden City AL7 3AX
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ascension Healthcare Development Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ascension Healthcare Development‘s full profile, request access.

Request a free trial

Ascension Healthcare Development Patents

Ascension Healthcare Development Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180030092-A1 Compounds Active 26-Nov-2014
US-12146004-B2 Polymyxin compounds and uses thereof Active 26-Nov-2014
US-20170073373-A1 Polymyxin derivatives and their use in combination therapy together with different antibiotics Inactive 11-Mar-2014
GB-201309248-D0 Compounds and combinations Inactive 22-May-2013
WO-2014188178-A1 Polymyxin derivatives and their use in combination therapy together with different antibiotics Inactive 22-May-2013 C07K7/62
To view Ascension Healthcare Development’s complete patent history, request access »

Ascension Healthcare Development Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ascension Healthcare Development FAQs

  • When was Ascension Healthcare Development founded?

    Ascension Healthcare Development was founded in 2012.

  • Where is Ascension Healthcare Development headquartered?

    Ascension Healthcare Development is headquartered in Welwyn Garden City, United Kingdom.

  • What is the size of Ascension Healthcare Development?

    Ascension Healthcare Development has 8 total employees.

  • What industry is Ascension Healthcare Development in?

    Ascension Healthcare Development’s primary industry is Drug Discovery.

  • Is Ascension Healthcare Development a private or public company?

    Ascension Healthcare Development is a Private company.

  • What is Ascension Healthcare Development’s current revenue?

    The current revenue for Ascension Healthcare Development is .

  • How much funding has Ascension Healthcare Development raised over time?

    Ascension Healthcare Development has raised $3.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process